Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 15;7(10):1992-9.
eCollection 2015.

MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1

Affiliations

MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1

Cai Lv et al. Am J Transl Res. .

Abstract

Deregulated expression of miRNAs is related to progression and initiation of human cancers. Although miR-495 has identified in various tumors, its expression and function in renal cell carcinoma (RCC) is still unknown. In this study, we found that the expression of miR-495 was downregulated in RCC cell lines and tissues. Ectopic expression of miR-495 induced G0/G1 phase arrest and suppressed cell proliferation and migration in RCC cell lines. We further validated SATB1 was a direct target of miR-495 in RCC. In addition, re-expression of SATB1 reversed the miR-495-induced inhibition of cell proliferation and migration. These data suggest that miR-495 functions as a tumor suppressor and may be a promising therapeutic target in RCC in the future.

Keywords: Renal cell carcinoma; SATB1; miR-495; microRNAs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
miR-495 was downregulated in RCC cell lines and tissues (A) qRT-PCR analysis was used to detect the expression of miR-495 in four human renal cell carcinoma cells lines (769-P, 786-O, A498, SN12-PM6) and one normal renal cell line (HK-2). (B) qRT-PCR analysis was used to detect the expression of miR-495 in clinical RCC specimens and normal tissues. (C) The relative expression of miR-495 was downregulated in clinical RCC specimens compared with their corresponding nontumor tissues.
Figure 2
Figure 2
Re-expression of miR-495 suppressed RCC cell proliferation (A) qRT-PCR was performed to measure the miR-495 expression in 786-O cells at 48 hours after miR-495 mimic transfection. (B) Cell cycle assays showed that 786-O cells transfected with miR-495 mimics had an obvious cell cycle arrest at the G0/G1 phase. (C) Re-expression of miR-495 suppressed 786-O cells proliferation using CCK-8 assay.
Figure 3
Figure 3
Overexpression of miR-495 inhibited RCC cell migration. Overexpression of miR-495 repressed the 786-O cells migration.
Figure 4
Figure 4
miR-495 downregulated SATB1 expression by directly targeting its 3’-UTR. A. SATB1 gene harbored a potential miR-495 binding site using a stringent bioinformatics approach. B. Luciferase reporter assay showed that the luciferase reporter activity decreased approximately 67% in the 786-O cells containing the SATB1 WT 3’UTR fragment. C. The ectopic expression of miR-495 suppressed the SATB1 mRNA by using qRT-PCR. D. Overexpression of miR-495 inhibited the SATB1 protein by using Western blot.
Figure 5
Figure 5
Re-expression of SATB1 reversed the miR-495-induced inhibition of cell proliferation and migration. A. The protein expression of SATB1 was measured by using Western blot. B. The data of CCK8 assay showed that re-expression of SATB1 increased the miR-495 overexpressing 786-O cells proliferation. C. Cell cycle assays showed that miR-495 overexpressing 786-O cells transfected with SATB1 vector had an obvious cell cycle at the S phase. D. The migration abilities of miR-495 overexpressing 786-O cells were increased after SATB1 transfection.

Similar articles

Cited by

References

    1. Liang J, Zhang Y, Jiang G, Liu Z, Xiang W, Chen X, Chen Z, Zhao J. MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma. Oncol Res. 2013;21:83–91. - PubMed
    1. Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem. 2010;43:150–158. - PubMed
    1. Li W, Liu M, Feng Y, Xu YF, Huang YF, Che JP, Wang GC, Yao XD, Zheng JH. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1) Br J Cancer. 2014;111:1188–1200. - PMC - PubMed
    1. Lopez-Lago MA, Thodima VJ, Guttapalli A, Chan T, Heguy A, Molina AM, Reuter VE, Motzer RJ, Chaganti RS. Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression. Cancer Res. 2010;70:9682–9692. - PMC - PubMed
    1. Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, Li Y, Nelson RA, Mu B, Onami SH, Wu JJ, Ruel NH, Wilczynski SP, Gao H, Covarrubias M, Figlin RA, Weiss LM, Wu H. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One. 2012;7:e35661. - PMC - PubMed

LinkOut - more resources